Does Novabay Pharmaceuticals Inc (AMEX:NBY) warrant a purchase right now? What to Consider Before Making a Decision

Novabay Pharmaceuticals Inc (AMEX:NBY) shares traded 15.67% higher at $0.16 on Wall Street last session.

NBY stock price is now 57.48% away from the 50-day moving average and -39.12% away from the 200-day moving average. The market capitalization of the company currently stands at $6.17M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target of $1.10, Ladenburg Thalmann recently initiated with Buy rating for Novabay Pharmaceuticals Inc (AMEX: NBY). On July 06, 2018, H.C. Wainwright reiterated its ‘Buy’ rating on the stock and kept its target price maintained at $4, while ‘Laidlaw’ rates the stock as ‘Buy’

A total of 0.03% of the company’s stock is owned by insiders.

During the past 12 months, Novabay Pharmaceuticals Inc has had a low of $0.06 and a high of $1.28. As of last week, the company has a debt-to-equity ratio of 15.12, a current ratio of 0.92, and a quick ratio of 0.75. The fifty day moving average price for NBY is $0.1028 and a two-hundred day moving average price translates $0.2675 for the stock.

The latest earnings results from Novabay Pharmaceuticals Inc (AMEX: NBY) was released for 2023-12-31. According to the Biotechnology Company, earnings per share came in at -1.27, missing analysts’ expectations of -0.55 by -0.72. This compares to -$0.19 EPS in the same period last year. The net profit margin was -129.47% and return on equity was -242.90% for NBY. The company reported revenue of $2.63 million for the quarter, compared to $2.34 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.48 percent. For the current quarter, analysts expect NBY to generate $3.15M in revenue.

Related Posts